Evaluation of the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Aerobic Capacity in Children With Cystic Fibrosis Aged 6-11 Years: Actual Observations and Clinical Perspectives - Pérez-Ruiz, M; Te Bos, M; Fernández-García, P; de Manuel, C; Morales-Tirado, A; Lopez-Neyra, A; de Valbuena, MR; Rubio, M; Sanz-Santiago, V (Archivos De Bronconeumologia, 2025)